The drug Januvia is a widely-popular diabetes treatment option known as an “incretin mimetic.” The drug is manufactured by pharmaceutical giant Merck Sharp & Dohme, Corp. (hereinafter, “Merck”) and is one of the top-selling diabetes medications to date. However, an increasing number of Januvia users are reporting the sudden and... Read more »

According to the details of a quarterly report filed by drug giant AstraZeneca, it has agreed to settle 84 cases with plaintiffs having filed Byetta lawsuits alleging serious injury. The drug maker did not immediately reveal the amount of each settlement, and its report also reveals at least 409 other... Read more »

Dara Goldstein, individually and as successor in interest of the estate of Samuel Goldstein, has submitted a short form complaint for monetary damages against Merck, Sharpe & Dohme. The plaintiff claims that her now deceased husband developed pancreatic cancer and subsequently died as a direct result of taking the diabetes... Read more »